首页> 外文期刊>International journal of clinical oncology >Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial
【24h】

Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial

机译:癌症患者疲劳风险接受抗EGFR单克隆抗体:随机对照试验的系统评价和荟萃分析结果

获取原文
获取原文并翻译 | 示例
           

摘要

To evaluate the association between fatigue and anti-epidermal growth factor receptor monoclonal antibodies (anti-EGFR MAbs), we conducted the first meta-analysis to access the incidence and risk of fatigue associated with anti-EGFR MAbs.
机译:为了评估疲劳和抗表皮生长因子受体单克隆抗体(抗EGFR mAb)之间的关联,我们进行了第一次荟萃分析以获得与抗EGFR mAb相关的疲劳的发生率和风险。

著录项

  • 来源
  • 作者单位

    Sun Yat Sen Univ Sun Yat Sen Mem Hosp Guangdong Prov Key Lab Malignant Tumor Epigenet &

    Sun Yat Sen Univ Sun Yat Sen Mem Hosp Guangdong Prov Key Lab Malignant Tumor Epigenet &

    Sun Yat Sen Univ Sun Yat Sen Mem Hosp Dept Pharm 107 Yanjiang West Rd Guangzhou 510120;

    Sun Yat Sen Univ Sun Yat Sen Mem Hosp Guangdong Prov Key Lab Malignant Tumor Epigenet &

    Sun Yat Sen Univ Sun Yat Sen Mem Hosp Guangdong Prov Key Lab Malignant Tumor Epigenet &

    Sun Yat Sen Univ Sun Yat Sen Mem Hosp Guangdong Prov Key Lab Malignant Tumor Epigenet &

    Sun Yat Sen Univ Sun Yat Sen Mem Hosp Guangdong Prov Key Lab Malignant Tumor Epigenet &

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Anti-EGFR MAbs; Fatigue; Meta-analysis;

    机译:抗EGFR MAB;疲劳;META分析;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号